Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
- PMID: 31480335
- PMCID: PMC6747368
- DOI: 10.3390/ijms20174262
Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
Abstract
Cyclo-oxygenase (COX) inhibitors are among the most commonly used drugs in the western world for their anti-inflammatory and analgesic effects. However, they are also well-known to increase the risk of coronary events. This area is of renewed significance given alarming new evidence suggesting this effect can occur even with acute usage. This contrasts with the well-established usage of aspirin as a mainstay for cardiovascular prophylaxis, as well as overwhelming evidence that COX inhibition induces vasodilation and is protective for vascular function. Here, we present an updated review of the preclinical and clinical literature regarding the cardiotoxicity of COX inhibitors. While studies to date have focussed on the role of COX in influencing renal and vascular function, we suggest an interaction between prostanoids and T cells may be a novel factor, mediating elevated cardiovascular disease risk with NSAID use.
Keywords: T cells; adaptive immunity; coronary disease; cyclo-oxygenase; immune-mediated hypertension; prostanoids; vascular dysfunction.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6747368/bin/ijms-20-04262-g001.gif)
Similar articles
-
Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natur a l Substitutes.Curr Pharm Des. 2017;23(6):952-960. doi: 10.2174/1381612822666161006144942. Curr Pharm Des. 2017. PMID: 27719647 Review.
-
Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?Lancet. 2007 Dec 22;370(9605):2138-51. doi: 10.1016/S0140-6736(07)61909-6. Lancet. 2007. PMID: 18156036 Review.
-
Anti-inflammatory drugs in the 21st century.Subcell Biochem. 2007;42:3-27. doi: 10.1007/1-4020-5688-5_1. Subcell Biochem. 2007. PMID: 17612044 Review.
-
Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.Aliment Pharmacol Ther. 2004 Jan 15;19(2):197-208. doi: 10.1111/j.0269-2813.2004.01834.x. Aliment Pharmacol Ther. 2004. PMID: 14723611 Review.
-
Selective cyclo-oxygenase-2 inhibitors: cardiovascular and gastrointestinal toxicity.Dig Liver Dis. 2001 Dec;33 Suppl 2:S21-8. doi: 10.1016/s1590-8658(01)80155-9. Dig Liver Dis. 2001. PMID: 11827359 Review.
Cited by
-
Interplay Between Diabetes Mellitus and the Occurrence of Osteoarthritis and Associated Conditions in Women of Menopausal Age.Cureus. 2024 Apr 17;16(4):e58502. doi: 10.7759/cureus.58502. eCollection 2024 Apr. Cureus. 2024. PMID: 38765429 Free PMC article. Review.
-
Effect of miR-412-5p-loaded exosomes in H9c2 cardiomyocytes via the MAPK pathway.Iran J Basic Med Sci. 2024;27(6):755-760. doi: 10.22038/IJBMS.2024.75590.16365. Iran J Basic Med Sci. 2024. PMID: 38645496 Free PMC article.
-
Royal Jelly, A Super Food, Protects Against Celecoxib-Induced Renal Toxicity in Adult Male Albino Rats.Can J Kidney Health Dis. 2024 Mar 10;11:20543581241235526. doi: 10.1177/20543581241235526. eCollection 2024. Can J Kidney Health Dis. 2024. PMID: 38476622 Free PMC article.
-
Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment.Front Immunol. 2022 Dec 22;13:1051082. doi: 10.3389/fimmu.2022.1051082. eCollection 2022. Front Immunol. 2022. PMID: 36618407 Free PMC article. Review.
-
Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study.Front Neurol. 2022 Oct 20;13:1018521. doi: 10.3389/fneur.2022.1018521. eCollection 2022. Front Neurol. 2022. PMID: 36341096 Free PMC article.
References
-
- Khan S.I., Shihata W.A., Andrews K.L., Lee M.K.S., Moore X.L., Jefferis A.M., Vinh A., Gaspari T., Dragoljevic D., Jennings G.L., et al. Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat. FASEB J. 2019;33:1510–1521. doi: 10.1096/fj.201701498RR. - DOI - PubMed
-
- Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., Day R., Ferraz M.B., Hawkey C.J., Hochberg M.C., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N. Engl. J. Med. 2000;343:1520–1528. doi: 10.1056/NEJM200011233432103. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources